UNI MEDICAL (02666.HK): Wholly-owned Subsidiary China Universal Leasing to Issue Third Onshore Corporate Bond Tranche of Up to RMB 1 Billion
- The balance of the principal amount of the Corporate Bonds was RMB 2.9 billion as at the date of the announcement, and the bonds will be issued in several tranches.
- The third tranche has a basic term of five years, at the end of the third and fourth years of which the Issuer will be entitled to a repurchase option and a coupon rate adjustment option, while investors will be entitled to a sell-back option.
- The par value and issue price are RMB 100.00 each, the place of issuance is the Shanghai Stock Exchange and the Issuer has an AAA credit rating.
NewTimeSpace News: On 18 September 2026, Genertec Universal Medical Group Company Limited (02666.HK) announced that China Universal Leasing Co., Ltd., a wholly-owned subsidiary of the Company, has received approval from the CSRC for the public issuance of corporate bonds with an aggregate principal amount up to RMB 8 billion to qualified investors in the PRC, and that the balance of the principal amount of the Corporate Bonds was RMB 2.9 billion as at the date of the announcement.
The Corporate Bonds will be issued in several tranches, and the principal amount of the Issuer's third tranche in 2026 will not exceed RMB 1 billion (inclusive), with a basic term of five years, at the end of the third year and the fourth year of which the Issuer will be entitled to a repurchase option and a coupon rate adjustment option, while the investors will be entitled to a sell-back option. The third tranche will be issued off-line to qualified investors by price enquiring and placing, with a par value and an issue price of RMB 100.00 each, at the Shanghai Stock Exchange and with an AAA credit rating for the Issuer, and is expected to be issued off-line from 21 September 2026.
According to the CSRC approval, the issuance of the Corporate Bonds will be completed within 24 months from the date of such approval, and the Company will make further announcement(s) in relation to the updated progress of the third tranche and the issuance of the remaining bonds, if any, as and when appropriate.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- UNI MEDICAL(02666.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 1.26 billion, YoY increase of 2.8%
- UNI MEDICAL (02666.HK): Subsidiary completes issuance of RMB 250 million two-year onshore medium-term notes at coupon rate of 1.73%
- UNI MEDICAL (02666.HK): wholly-owned subsidiary completes issuance of RMB 250 million second tranche domestic MTN, coupon 1.79%
- UNI MEDICAL(02666.HK): Subsidiary Plans to Issue Up to RMB1 Billion Corporate Bonds with AAA Credit Rating
